Oregon’s Psilocybin Services Program is coming together. On Friday, regulators announced that the state had approved the first psychedelic testing lab.
Oregon Health Authority (OHA), a state agency, announced that Rose City Laboratories, LLC will be granted the license.
Angie Allbee, Oregon Psilocybin Services’ Section Manager said that laboratory testing is necessary to ensure the safety of products containing psilocybin. Accurate labeling allows clients participating in administration sessions to use products that are suitable for their needs.
The OHA approved the first-ever state-issued license for a psilocybin manufacturer last month. Last month, regulators approved the state’s first license ever for a psilocybin producer.
The historic initiative approved by voters required officials to issue licenses for manufacturing, testing, and administering psilocybin before January 2, 2023. OPS stated it “anticipates granting licenses to service centre applicants in the next months.”
OHA has approved 60 psilocybin workers permits to date. As of Wednesday, 302 worker license and permit applications have been sent to state.
OHA stated that “Administration Sessions can only be held in licensed service centres statewide offering psilocybin produced by licensed manufacturers, and tested by certified laboratories”, OHA. “Licensed service centres may contract or hire licensed facilitators to support preparation, administration, and integration sessions with their clients.”
The implementation of the Oregon psilocybin program has not been without its hiccups.
The question of local access is a big one, since more than 100 cities in the state have implemented two-year bans that prohibit the establishment of service centers within their jurisdictions.
The Netherlands-based Synthesis institute, which invested heavily to create a program of training for facilitators who will administer psilocybin in the future centers, recently revealed it had run out of funds.
The rulemaking process has also been contentious. Some advocates are concerned that the regulators seem to be prioritizing the management of the psilocybin service program by for-profit corporations over indigenous and community-based groups.
Marijuana Moment tracks more than 1,000 cannabis and psychedelics bills, as well as drug policy legislation in state legislatures this year. Patreon supporters who pledge at least $25/month gain access to our interactive charts, maps and hearing calendar.
Discover more about our marijuana bills tracker. Become a Patreon supporter to gain access.
—
The Oregon Psilocybin Advisory Board is also promoting research on the therapeutic potentials of psychedelics. The board approved the formation of a research group in 2021 to provide a comprehensive overview of the history, science and culture of Psilocybin.
Colorado voters approved a ballot measure to legalize many psychedelics, including psilocybin.
Colorado Senators have approved in committee a bill on Thursday that will establish a regulatory framework under the voter-approved initiative for legal psychedelics.
These developments coincide with a wave of legislative efforts to change state laws that govern psychedelic drugs.
After final approval by the Senate, Washington State’s bill to promote psilocybin research and create a program to allow therapeutic access to psychedelics for mental health treatment will be heading to the Governor’s desk.
Last week, a Nevada Senate Committee approved a revised version of a bill that would establish a new group to study psychedelics as well as develop a plan for regulated access to therapeutic purposes.
Last week, the Hawaii Senate passed a bill to establish an advisory council that would examine possible regulations to allow access to federal “breakthrough therapy” such as psilocybin or MDMA.
Minnesota lawmakers have attached , a bill that creates a task force to prepare the state for a possible legalization of psychedelics to a large-scale health legislation that may reach the House floor in the near future.
A Republican Massachusetts legislator filed three new reform bills for psychedelics, including proposals to legalize substances such as psilocybin or reschedule MDMA while waiting for federal approval and setting a price limit on therapeutic access.
These are only a few of the reforms being considered by legislators in the United States this session.
Based on statistical modelling of policy trends, an analysis published last year in the American Medical Association journal concluded that most states will legalize psychedelics before 2037.
A national survey published last month revealed that a majority of U.S. citizens support the legalization of psychedelic therapy, and are in favor decriminalizing substances such as psilocybin or MDMA.
Booker says that lawmakers will’resurrect’ Marijuana Banking bill so that ‘hundreds of businesses’ don’t shut down
Image courtesy of Workman.
The post Oregon Approves the First-Ever Psilocybin Testing Laboratory as State Prepares to Open Psychedelic Services first appeared on Marijuana Moment.
